Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...

There are molecular testing gaps in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment, highlighting ...

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

Although treatment with high-dose corticosteroids can reduce mast burden and improve symptoms such as pain, congestive heart failure, and cytopenia in patients with MCL, their effects are frequently ...

Break Through Cancer, a Boston-based cancer research foundation, has launched a clinical trial to evaluate the feasibility of ...

The US Food and Drug Administration (FDA) has accepted the supplemental new drug application (sNDA) for Inqovi (decitabine ...

I celebrated five years since my bone marrow transplant with a surprise video from my donor, a beautiful reminder of the life ...

An announcement from Moleculin Biotech ( ($MBRX) ) is now available. On July 9, 2025, Moleculin Biotech announced that the Regulation Agency for ...

Moleculin Biotech (MBRX) announced that the Regulation Agency for Medical and Pharmaceutical Activities, or RAMPA, in the country of Georgia has ...

Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) is one of the most promising stocks according to Wall Street analysts. On June 24, ...